We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

A Closer Look At Ariosa After Fed. Circ. Denies Rehearing

Law360, New York (December 11, 2015, 10:15 AM EST) -- William A. Carroll

Heidi Dare In Ariosa Diagnostics Inc. v. Sequenom Inc., a Federal Circuit panel held that certain prenatal diagnostic testing claims in U.S. patent no. 6,258,540 ("the '540 patent") were invalid under 35 U.S.C. § 101 as directed to a natural phenomenon.[1] The court's holding rested on its conclusion that the claims failed the "inventive concept" test of Mayo v. Prometheus.[2]

The Ariosa case raises a critical question of whether Mayo permits the interplay between a natural principle and the steps of a process claim to supply an inventive concept under § 101, or whether the inventive concept must reside...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS